Quick Answer
Glucotrack, Inc. reported Net Income of -$19.39 million for fiscal year 2025.
Glucotrack, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$19.39M | +14.2% |
| 2024 | -$22.60M | -218.4% |
| 2023 | -$7.10M | -60.0% |
| 2022 | -$4.43M | -9.0% |
| 2021 | -$4.07M | -50.9% |
| 2020 | -$2.70M | -176.7% |
| 2019 | $3.52M | +152.4% |
| 2018 | -$6.72M | -165.0% |
| 2017 | $10.33M | +290.9% |
| 2016 | -$5.41M | +7.4% |
| 2015 | -$5.84M | -296.0% |
| 2014 | $2.98M | +130.4% |
| 2013 | -$9.80M | -253.4% |
| 2012 | -$2.77M | -17.3% |
| 2011 | -$2.36M | +15.2% |
| 2010 | -$2.79M | -131.9% |
| 2009 | -$1.20M | +21.4% |
| 2008 | -$1.53M | +4.0% |
| 2007 | -$1.59M | -24.2% |
| 2006 | -$1.28M | -21.5% |
| 2005 | -$1.06M | -266.2% |
| 2004 | -$288.2K | +17.7% |
| 2003 | -$350.3K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.17M | +18.0% | +12.3% |
| June 30, 2025 | -$4.76M | -5.9% | +30.4% |
| March 31, 2025 | -$6.83M | -133.4% | -34.3% |
| September 30, 2024 | -$5.09M | -128.8% | -13.3% |
| June 30, 2024 | -$4.49M | -281.7% | -53.4% |
| March 31, 2024 | -$2.93M | -127.6% | -31.7% |
| September 30, 2023 | -$2.22M | -139.5% | -89.0% |
| June 30, 2023 | -$1.18M | -4.3% | +8.6% |
- Glucotrack, Inc. showed an increase of +14.2% in Net Income compared to the prior fiscal year.
- Over the 2003–2025 period, Glucotrack, Inc.’s net income has declined by 5434.8% (from -$350.3 thousand to -$19.39 million).
- The most recent figure is from Glucotrack, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: